Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
<p style="text-align:justify;"> <b>Background:</b> To investigate disease progression the first 12 months after diagnosis in children with type 1 diabetes negative (AAB negative) for pancreatic autoantibodies [islet cell autoantibodies(ICA), glutamic acid decarboxylase a...
Asıl Yazarlar: | Pörksen, S, Laborie, L, Nielsen, L, Louise Max Andersen, M, Sandal, T, De Wet, H, Schwarcz, E, Aman, J, Swift, P, Kocova, M, Schönle, E, de Beaufort, C, Hougaard, P, Ashcroft, F, Molven, A, Knip, M, Mortensen, H, Hansen, L, Njølstad, P |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
BioMed Central
2010
|
Benzer Materyaller
-
SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group
Yazar:: Porksen, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Monogenic diabetes
Yazar:: Kavvoura, FK, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Yazar:: Davison, L, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
Yazar:: Suhana Bedi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01) -
Editorial: Personalized therapies for monogenic diabetes
Yazar:: Maurizio Delvecchio, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)